Search

Dishman Pharmaceuticals & Chemicals

Sector: Healthcare | Industry: Drugs & Pharma
R 301.20 7.95  | 2.71% 96.54% 30.15 4,858.77
NSE Price: May 29, 2017 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE May 29, 2017 301.20 7.95 2.71% 288.20 293.25 1,615,604 278.00 - 304.20
BSE May 29, 2017 301.05 8.40 2.87% 293.00 292.65 460,499 278.10 - 304.30
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE FREE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
6M Average Volume: 1,399,067 P/B: 1.01 NSE Code: DISHMAN
52-Week Range: R 127.95 - 347.00 Dividend Yield: 0.33% BSE Code: 532526
TTM EPS: R 9.99 Book Value: R 297.94 Face Value: R 2
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 38
Price Graph
  • S&P BSE Sensex


Please wait while we are fetching data...
Are you missing an opportunity to invest in great stocks at low valuations?
There are thousands of listed companies in India and yet only a handful that are worth investing at a particular time and at a particular price.

Our equity team has sifted through hundreds of companies and selected stocks that you should invest in. This list now has 38 stocks on it, and new ones are being added every month. Thousands of our members are using stagnant equity markets to buy great stocks at low prices. Membership of Value Research Stock Advisor is available at a 40% to 60% discount. Learn more and become a member
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 0.46 7.85 9.13
Net Profit 42.79 19.46 16.40
EPS 42.82 19.49 16.42
Book Value 17.34 12.14 10.65
Average
Operating Margin 27.37 26.10 24.72
Net Margin 10.54 8.48 7.64
Return on Networth 12.77 10.89 9.86
Return on Investment 14.40 12.75 11.93
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue -36.42 -10.17 -19.89
Operating Profit -49.12 -29.86 -34.84
Net Profit -69.93 -56.99 -72.37
EPS -69.57 -56.99 -72.30
TTM
Revenue -2.25 6.22 4.50
Operating Profit -6.59 5.02 4.91
Net Profit -9.62 7.51 0.98
EPS -9.67 7.62 1.04
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Dishman Pharma & Chem 4,858.77 1,672.48 162.05 9.50 12.77 1.01 30.15
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Apr 04, 2017 Bhadra Raj Holdings Pvt Ltd  Buy Off Market 97,891,898 324.60 317,757.10
Nov 18, 2014 HDFC Standard Life Insurance Co. Ltd.  Sell Market 254,641 142.60 363.12
Jun 12, 2014 HDFC Standard Life Insurance Co. Ltd.  Sell Market 242,218 116.70 282.67
Apr 23, 2014 Kotak Mahindra Investments Ltd.  Sell - 2,730,000 92.75 2,532.08
Apr 23, 2014 Kotak Mahindra Prime Ltd.  Sell - 90 92.75 0.08
Fund Houses invested in the stock
Fund Mar-17 Dec-16 Sep-16 Jun-16 Mar-16
L&T Mutual Fund 4.400 3.432 1.997 - -
Aditya Birla Sun Life Mutual Fund 2.271 2.252 2.150 3.564 3.566
Tata Mutual Fund 1.884 1.307 1.177 - -
UTI Mutual Fund 0.530 0.469 0.527 0.075 0.075
IDFC Mutual Fund 0.340 - - - -
LIC Mutual Fund 0.028 0.028 0.129 0.102 0.102
Indiabulls Mutual Fund NA 0.023 0.025 - -
Figures given above are % of equity capital
News & Announcements
Contact Information

Company: Dishman Pharmaceuticals & Chemicals Ltd.

Address: Bhadr Raj Chambers, Swastik Cross Road, Navrangpura, Ahmedabad, Gujarat - 380009 | Phone: 079- 26443053 / 26445807 / 26560089 | Fax: 079- 26420198

Email: [email protected]

Website: www.dishmangroup.com

Registrar & Transfer Agent: Link Intime India Pvt Ltd.

Address: C 101, 247 Park, LBS Marg, Vikhroli (W), Mumbai(Old Address:) C-13 Pannalal Silk Compound, L B S Marg, Bhandup Mumbai Maharashtra, C 101, 247 Park, LBS Marg, Vikhroli (West) | Phone: 91-022-49186000/49186270 | Fax: 91-022-49186060

Email: [email protected]

Website: www.linkintime.co.in

comments powered by Disqus
Essential checks
Altman Z-Score
3.53
Piotroski F-Score
8
Modified C-Score
4
1-Year Price to Earnings
30.15
1-Year Price to Book
1.01
Earnings Yield
EBIT / Enterprise value
5.11%
PEG
Price / Earnings to growth ratio
0.28